Today: 12 November 2025
Subscribe
Browse Category

Investment Trends News 14 October 2025 - 17 October 2025

Credit ‘Cockroach’ Jitters Shake Markets: Stocks Slide Globally as Gold Hits Record High

Credit ‘Cockroach’ Jitters Shake Markets: Stocks Slide Globally as Gold Hits Record High

Banking Scare Sparks Global Selloff A new bout of credit jitters is roiling global markets, sparked by trouble at a pair of midsize U.S. banks. On Thursday, Utah-based Zions Bancorporation and Phoenix-based Western Alliance Bancorp revealed they face hefty losses on problematic loans – including a $50 million charge-off at Zions and a $100 million bad loan at Western tied to alleged borrower fraud theguardian.com. While relatively small banks (each under $10 billion market cap), the revelations sent shockwaves through the financial sector. “The event drew inevitable comparisons to the regional bank stress that followed the collapse of Silicon Valley Bank (SVB) in
17 October 2025
 ·  ·  ·  · 
Tesla Stock’s October Shock: Record Sales, New “Affordable” Models & Wall Street’s Verdict

Tesla’s Stock Rollercoaster: Record Sales and “Affordable” Models Spark Wild Swings

Key Facts: – On Oct. 17, Tesla shares trade around $429 per share, after soaring to ~$453 on Oct. 6 (a 52-week high) and then swinging with earnings and product news ts2.tech marketbeat.com. – Q3 2025 deliveries hit a record 497,099 vehicles (up 7.4% YoY), driven by a late-quarter rush to claim the expiring $7,500 U.S. EV tax credit reuters.com ts2.tech. – New low-cost Model 3/Y “Standard” editions were unveiled on Oct. 7 (starting ~$36,990/$39,990) reuters.com, but the modest $4–5K price cuts disappointed investors and knocked TSLA down ~4.5% on the news reuters.com. – Analysts remain polarized: top bulls (Wedbush’s
17 October 2025
 ·  ·  ·  ·  · 
Rigetti’s 5,500% Quantum Leap: Stock Skyrockets Then Slides as Hype Meets Reality

Rigetti’s 5,500% Quantum Leap: Stock Skyrockets Then Slides as Hype Meets Reality

RGTI Stock’s Roller-Coaster Week Rigetti’s stock enjoyed a meteoric rise early in the week, then suffered a sharp reversal. Shares of RGTI surged to fresh highs around $58 – the upper end of its 52-week range marketbeat.com – before tumbling roughly 15% in a single day on Thursday, Oct. 16 finviz.com. The sell-off dropped the stock to the high-$40s, trimming its weekly gains. Rigetti wasn’t alone: other quantum computing darlings like IonQ and D-Wave Quantum also sank ~9% on Thursday amid a broad pullback swingtradebot.com. Traders appear to have cashed in profits after a torrid run, as concerns mounted that
17 October 2025
 ·  ·  ·  ·  ·  ·  · 
Omeros Stock Explodes 146% on Surprise $2.1B Novo Nordisk Deal – What Comes Next?

Biotech Bombshell: Omeros Stock Skyrockets on $2.1B Novo Nordisk Deal – What’s Next?

Stock Performance: Recent Surge and Volatility Omeros shares were trading around $4–$4.60 through early October, then exploded on Oct. 15. Data from the company’s IR site show OMER jumped from $4.10 (Oct 14 close) to $10.42 by Oct 15 close investor.omeros.com. Intraday on Oct 15, it even hit a high around $12.10. This roughly 150% one-day surge was driven by the Novo Nordisk deal (see below). Trading volume was staggering: Benzinga reports ~89.2 million shares traded (vs. a ~1.1M daily average) during the rally benzinga.com. By mid-October 16 pre-market, OMER was around $9–10 per share – still far above levels seen
16 October 2025
 ·  ·  ·  ·  ·  · 
Theriva Biologics (TOVX) Stock Soars 92% on Oncolytic Virus Trial News – Can the Rally Last?

Theriva Biologics (TOVX) Stock Soars 92% on Oncolytic Virus Trial News – Can the Rally Last?

Recent News and Pipeline Developments Theriva Biologics (NYSE American: TOVX) has been in the news for its upcoming conference presentations and strong trial data. On October 13, 2025 the company announced that expanded data from the VIRAGE Phase 2b trial (metastatic pancreatic cancer) will be presented at the ESMO 2025 Congress on October 20 sec.gov. In VIRAGE, the oncolytic adenovirus VCN-01 is given with gemcitabine/nab‑paclitaxel standard chemotherapy. Interim abstract data (recently filed with the SEC) show that VCN-01 + chemotherapy substantially improved overall survival (OS) and progression-free survival (PFS) versus chemotherapy alone sec.gov sec.gov. Patients receiving VCN-01 saw median OS up to
15 October 2025
 ·  ·  ·  · 
Hims & Hers Health Stock Skyrockets amid Weight-Loss Mania – But FDA Scrutiny Looms

Hims & Hers Stock Soars on New Menopause Care Expansion – What Comes Next?

Hims & Hers’ women’s health platform (Hers) now offers specialized menopause and perimenopause care investors.hims.com. The new service is aimed at improving access to hormone therapies (estradiol, progesterone, etc.) for symptoms like hot flashes and sleep issues, expanding a platform that already serves over 500,000 women. The October 15 jump in HIMS stock was driven by the menopause announcement. Investors saw the new specialty as a major driver of future growth, helping Hims & Hers address a long-ignored need in women’s health. As Benzinga reported, the stock closed the day up about 10–13% (trading near $60) after the news benzinga.com.
15 October 2025
 ·  ·  ·  ·  · 
Solar Surge: T1 Energy (TE) Stock Rockets After Major U.S. Deals, CEO Champions “American Energy” Vision

Solar Surge: T1 Energy (TE) Stock Rockets After Major U.S. Deals, CEO Champions “American Energy” Vision

Stock Performance and Recent Moves T1 Energy’s shares have been on a tear in 2025. Before today’s jump, TE closed at $4.01 on Oct 14 (a 14.6% gain on the day) marketscreener.com. During premarket trading on Oct 15, the stock briefly touched $5.37 (up 34%) following the Nextracker news investing.com, before settling to around $4.91 (+22.6%) by 9:45 AM marketscreener.com. Over the year-to-date through Oct 14, TE was already up ~55% investing.com. The one-year total return now exceeds 250% investing.com. However, longer-term returns remain negative – about –70% over three years, reflecting early losses under the Freyr Battery era investing.com. Investors
15 October 2025
 ·  ·  ·  ·  · 
Recursion RXRX Stock Skyrockets: AI Breakthroughs and Big Pharma Deals Ignite Biotech Surge

Recursion RXRX Stock Skyrockets: AI Breakthroughs and Big Pharma Deals Ignite Biotech Surge

Volatile Stock Performance in October 2025 Recursion’s stock showed wild swings in early October. On Oct 7, 2025 the shares fell about 5.4% to ~$5.23 amid a broad market slump nasdaq.com. The very next day (Oct 8) the stock rebounded sharply, jumping roughly 16% to ~$6.08 ts2.tech. This put RXRX near the middle of its 52-week trading range (about $3.97–$10.87) ts2.tech. Trading volume on these moves was heavy, with tens of millions of shares changing hands as investors positioned for upcoming company news. By Oct 14, RXRX was around $5.89 stocktitan.net. This volatility appears driven by renewed enthusiasm for Recursion’s
15 October 2025
 ·  ·  ·  ·  · 
Quantum Rocket or Bubble? RGTI’s Stunning Surge Explained—And How It Stacks Up to IonQ, D‑Wave, and QUBT

Rigetti Stock Skyrockets Amid Quantum Computing Boom – Bubble or Breakthrough?

Rigetti Computing’s (RGTI) shares have surged into the mid-$50s in October 2025. In late Sept and early Oct, announcements of new contracts and technology milestones repeatedly sent the stock higher insidermonkey.com ts2.tech. Analysts note RGTI is trading on future promise more than current sales. Rigetti Stock Performance Rigetti’s stock has exploded higher in recent weeks. On Oct. 13, 2025, RGTI spiked about +25% intraday to a record ~$55.23 (closing $54.91) insidermonkey.com. This burst was largely in response to news that JPMorgan is investing $10 billion in “frontier” tech including quantum computing insidermonkey.com. As Insider Monkey reported, “Rigetti Computing surged to
15 October 2025
 ·  ·  ·  · 
FuelCell Energy Stock Skyrockets on AI Data Center Boom – 97% Revenue Surge Ignites Green Energy Hype

FuelCell Energy Stock Skyrockets on AI Data Center Boom – 97% Revenue Surge Ignites Green Energy Hype

FuelCell Rides AI-Fueled Market Momentum Shares of FuelCell Energy have been on a tear in recent weeks, riding a wave of optimism about clean energy’s role in powering artificial intelligence infrastructure. The stock is up over 150% in the past month and recently hit multi-month highs around the $11–12 level benzinga.com benzinga.com. On Wednesday (Oct. 15), FCEL traded roughly 26% below its 52-week peak of ~$14 stockstory.org, after more than doubling from late summer lows. This spike in market value has been driven by a series of catalysts. In early October, an analyst at H.C. Wainwright more than doubled the
15 October 2025
 ·  ·  ·  ·  · 
Nuclear SPAC Stock Skyrockets on Merger Frenzy: HOND Shares Soar as Terrestrial Energy Deal Nears

Nuclear SPAC Stock Skyrockets on Merger Frenzy: HOND Shares Soar as Terrestrial Energy Deal Nears

HOND stock has surged into the mid-$20s (around $24.98 as of Oct. 15, 2025) after trading in the high teens last week investing.com marketbeat.com. Its volume spiked (about 1.14 million shares on Oct. 13) and the stock gapped up from $18.86 to $21.69 at open on Oct. 13 marketbeat.com. – The catalyst is a proposed merger with Terrestrial Energy Inc., a next-gen nuclear reactor company. The SEC declared the merger’s S-4 registration effective on Sept. 26, and HCM II shareholders will vote on Oct. 20 to approve the deal businesswire.com businesswire.com. If approved, the combined firm will list on Nasdaq
15 October 2025
 ·  ·  ·  ·  · 
Market Mayhem: Tech Stocks Surge as Trade Truce Hopes Spark Rally – Gold & Silver Hit Sky-High Records

Market Mayhem: Tech Stocks Surge as Trade Truce Hopes Spark Rally – Gold & Silver Hit Sky-High Records

These developments set the stage for a choppy market. Below, we break down the details on trade, Fed policy, tech stock moves and expert analyses shaping the outlook. Market Rally on Trade Truce Hopes “U.S. stock markets rebounded on Monday with great vigor,” as the Nasdaq market report explains, rallying after a sharp selloff on Friday nasdaq.com. The catalyst was President Trump’s surprisingly soft tweet on Oct 12: “Don’t worry about China, it will all be fine! … The U.S.A. wants to help China, not hurt it.” nasdaq.com. This was interpreted as a hint that his planned 100% tariffs on
14 October 2025
 ·  ·  ·  ·  ·  ·  ·  · 
1 … 4 5 6 7 8 … 10
Go toTop